NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

BARK Rejects Buyout Offers and Bets Big on Standalone Growth

BARK rejects GNK/Lemonis offer as undervalued, notes Great Dane proposal withdrawn, ends strategic review to pursue standalone strategy and long-term shareholder value.

BARK Rejects Buyout Offers and Bets Big on Standalone Growth
Credit: BARK
Already have an account? Sign in.
03/20/2026 · 12:45 PM
BARK
/ Don’t stop at just one post.

Related↓

BARK Stock Jumps on Competing $1.10 Buyout Offer
01/14/2026 · 11:57 AM

BARK Stock Jumps on Competing $1.10 Buyout Offer

BARK stock surges as GNK Holdings and Marcus Lemonis submit $1.10/share buyout offer, topping Great Dane Ventures' previous bid by 22%.

/ Subscriber only
/ Read more

Feed↓

Adobe Delivers Record Q2 but Shares Fall After CFO Departure
06/11/2026 · 4:37 PM

Adobe Delivers Record Q2 but Shares Fall After CFO Departure

Adobe reported strong Q2 results and raised its full-year guidance, but shares fell after the company announced that CFO Dan Durn will step down on June 15 to pursue a new opportunity.

/ Subscriber only
Google Guarantees Anthropic’s First Major Data Center Leases in Landmark $35B Deal
Featured/ 06/11/2026 · 3:33 PM

Google Guarantees Anthropic’s First Major Data Center Leases in Landmark $35B Deal

TeraWulf, Cipher Digital, Hut 8, and Fluidstack secure major Anthropic leases backed by Google in a landmark $35 billion financing package.

/ Subscriber only
Adial Pharmaceuticals Acquires Azora and Raises Up to $64 Million for New Ulcerative Colitis Drug
06/11/2026 · 12:36 PM

Adial Pharmaceuticals Acquires Azora and Raises Up to $64 Million for New Ulcerative Colitis Drug

Adial Pharmaceuticals acquires Azora Therapeutics and raises up to $64 million to advance AT177, a novel colon-targeted therapy for ulcerative colitis. Phase 1 studies planned for mid-2027.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2026
Email address Subscribe